Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
ID: 335063Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/335063

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-310.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Imaging - Science Track Award for Research Transition (I/START), a federal grant aimed at supporting small research projects in neuroimaging methodologies. This funding opportunity encourages both new and established investigators to conduct "proof of concept" studies that advance understanding of central nervous system dysfunction related to substance use disorders, without the need for preliminary data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $150,000 available for one year. Applications are due by January 8, 2025, and interested parties can find more information and application details at the NIH grants website or contact the NIH OER Webmaster at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-21-310-Full-Announcement.html
    PAR-21-310.html
    The Imaging - Science Track Award for Research Transition (I/START), managed by the National Institutes of Health’s National Institute on Drug Abuse (NIDA), supports small research grants (R03) aimed at advancing neuroimaging methodologies among both new and established investigators. This funding opportunity emphasizes the importance of obtaining preliminary "proof of concept" neuroimaging data to facilitate significant insights into central nervous system dysfunction related to substance use disorders. Eligible applicants can include higher education institutions, nonprofits, state and local governments, and for-profit organizations. Applications are due periodically, with a maximum budget of $150,000 available for one year. The grant is designed for discrete, time-bound projects and does not necessitate preliminary data, making it particularly suitable for pilot studies. The proposal should fit within specific areas of interest to NIDA, such as the neurobiology of addiction and the implications of neurobiological changes due to substance use. Compliance with application instructions and NIH policies is critical for submission success, reflecting the agency’s commitment to cultivating research capabilities in the realm of substance use and neuroimaging technologies.
    Similar Opportunities
    Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Imaging - Science Track Award for Research Transition (I/START) grant opportunity, aimed at supporting small research projects in the field of neuroimaging, particularly related to substance use and addiction. This funding initiative encourages both new and established investigators to conduct "proof of concept" studies that can generate pilot data within a short timeframe and with limited resources. Eligible applicants include a diverse range of organizations, such as historically black colleges and universities, tribal governments, and faith-based organizations, with funding of up to $150,000 available for projects lasting a maximum of one year. Interested parties should submit their applications by January 8, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance.
    Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Imaging - Science Track Award for Research Transition (I/START)" aimed at advancing neuroimaging methodologies relevant to substance use disorder (SUD) research. This program encourages both new and established investigators to conduct small "proof-of-concept" studies within a one-year project period, with a funding ceiling of $150,000. The initiative is designed to lower barriers for researchers in adopting advanced imaging techniques, thereby contributing to significant advancements in understanding and addressing substance use challenges. Interested applicants can find more information and application details at the provided link, with the application deadline set for January 7, 2028.
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the D-START: Data Science Track Award for Research Transition (D/START), a federal grant aimed at supporting small research projects that utilize advanced data science techniques to address critical issues related to substance use and substance use disorders. This funding opportunity encourages investigators, particularly those newly entering the field or established researchers incorporating novel methodologies, to propose projects that can be executed quickly and efficiently, including pilot studies and secondary analyses of existing datasets. Grants of up to $100,000 per project per year are available for a maximum of two years, with a total of six to seven awards anticipated annually. Interested applicants should adhere to the application guidelines outlined in the NIH Application Guide, with the earliest submission date set for September 16, 2024, and applications due by 5:00 PM local time. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the D-START: Data Science Track Award for Research Transition (D/START) under the R03 Small Grant Program, aimed at funding projects that utilize advanced data science techniques to investigate substance use and substance use disorders (SUD). This opportunity encourages new and established researchers to apply innovative methodologies to address critical questions in addiction research, with a focus on small-scale projects that can provide preliminary data for larger studies. The program is particularly designed to foster collaborations from underrepresented groups in STEM and aims to expedite the development of robust research programs in addiction-related data science. Applicants can request budgets of up to $100,000 for a maximum of two years, with a total of six to seven awards available, amounting to $1 million per year for fiscal years 2025 to 2027. Interested parties should submit their applications electronically through Grants.gov by the closing date of September 7, 2027, and can direct inquiries to grantsinfo@nih.gov.
    AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the AIDS-Science Track Award for Research Transition (A-START), a federal grant aimed at supporting early career investigators in the fields of drug use, substance use disorder (SUD), and HIV/AIDS research. This funding opportunity encourages applications for Small Research Grant (R03) projects that can be conducted within a short timeframe and with limited resources, focusing on innovative research that integrates substance use with HIV treatment and prevention strategies. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and tribal governments, with funding available up to $1,000,000 over a project period not exceeding two years. Interested parties should submit their applications by January 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) to support innovative and exploratory research projects in neuroscience. This grant aims to facilitate early-stage studies that assess novel avenues of investigation, particularly those that may involve significant risk but hold the potential for breakthroughs in understanding neuroscience or developing new methodologies. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and tribal governments, with funding available up to $200,000 over two years. Interested parties should submit their applications by January 7, 2025, and can find additional information and application guidelines at the NIH website or contact grantsinfo@nih.gov for assistance.
    NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Sustainable Transformation of Institutional Research Rigor (STIRR) Program, a federal grant opportunity aimed at enhancing research rigor and transparency within academic and research institutions in the field of neuroscience. This initiative seeks to support innovative programs and strategies that promote high-quality research practices, emphasizing rigorous study design and transparent reporting to foster a culture of scientific integrity. The NIH plans to allocate approximately $3.5 million annually for up to five awards, with individual grants ranging from $150,000 to $800,000 over a three-year period. Interested applicants must submit their proposals by October 17, 2025, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program, a federal grant opportunity aimed at enhancing research rigor and transparency within academic and research institutions in the field of neuroscience. This initiative seeks to implement innovative programs that promote rigorous study design and transparent reporting, ultimately fostering a culture of high-quality research practices. Grants ranging from $150,000 to $800,000 are available, with a total funding pool of $3.5 million anticipated for at least five awards annually. Applications are due by October 17, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries or visit the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-24-020.html for more details.
    Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment," aimed at encouraging clinical research to explore novel non-invasive brain stimulation (NIBS) targets for treating substance use disorders (SUD). This initiative seeks applications for exploratory and developmental studies that will identify and validate neurobiological, cognitive, and behavioral responses to NIBS, with the goal of understanding mechanisms that could lead to reduced cravings and substance use. The NIH plans to allocate $1.5 million in funding for fiscal years 2024-2026, with an award ceiling of $500,000 per project phase, and key submission dates starting December 16, 2023. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders" (R61/R33), aimed at supporting innovative clinical research that explores the neurobiological mechanisms underlying substance use disorders (SUD). This initiative encourages applications that investigate neural circuitry and cognitive processes affecting substance use behavior, particularly in the context of the ongoing public health crisis related to SUDs, including the opioid epidemic. The R61/R33 mechanism allows for up to five years of funding, divided into an initial two-year R61 phase and a potential three-year R33 phase, contingent upon meeting specified milestones. Interested applicants can find more information and submit proposals by the application due date of March 13, 2026, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.